Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase 1 11Phase 1/2 8Phase 3 4Phase NA 1

Status

Active not recruiting 3Recruiting 2Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 8INDUSTRY 3

Study Type

Interventional 8

Sponsor

Cancer Type

Genitourinary 8

Conditions

Prostatic Neoplasms 7Metastatic Castration-resistant Prostate Cancer 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 155Carboplatin 147Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 119Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Pluvicto × Clear all
NCT06574880 2026-05-26

STARLiT

Case Comprehensive Cancer Center

Phase 1/2 Recruiting
45 enrolled
Genitourinary

Prostatic Neoplasms

NCT05113537 2026-04-13

UPLIFT

University of California, San Francisco

Phase 1/2 Recruiting
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT03042468 2025-09-17

Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC

Weill Medical College of Cornell University

Phase 1/2 Active not recruiting
50 enrolled 19 charts
Genitourinary

Prostatic Neoplasms

NCT05340374 2025-04-06

LuCAB

Peter MacCallum Cancer Centre, Australia

Phase 1/2 Active not recruiting
35 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT04430192 2024-11-08

LuTectomy

Peter MacCallum Cancer Centre, Australia

Phase 1/2 Active not recruiting
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT06329830 2024-09-19

LUNAAR

Baptist Health South Florida

Phase 1/2 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT03545165 2021-08-24

177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC

Weill Medical College of Cornell University

Phase 1/2 Terminated
6 enrolled 24 charts
Genitourinary

Prostatic Neoplasms

NCT03828838 2019-11-14

Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer

Radboud University Medical Center

Phase 1/2 Completed
10 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡